Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
131 JPY | +4,80 % | +10,08 % | -13,25 % |
Resumen de negocios
Número de empleados: 22
Ventas por actividad
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Formulation Development and Related Operations
100,0
%
| 59 | 100,0 % | 30 | 100,0 % | -50,35 % |
Ventas por región
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
75,6
%
| - | - | 22 | 75,6 % | - |
Japan
24,4
%
| 59 | 100,0 % | 7 | 24,4 % | -87,87 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 79 | 15/01/02 | |
President | 53 | 01/08/03 | |
Ken Fujioka
ADM | Chief Administrative Officer | 56 | 01/11/18 |
Chief Tech/Sci/R&D Officer | 55 | 15/01/02 | |
Hiroshi Akitomo
BRD | Director/Board Member | 63 | 01/06/02 |
Keiko Yamasaki
BRD | Director/Board Member | 74 | 15/01/02 |
Masaru Fukui
AUD | Comptroller/Controller/Auditor | 75 | 01/09/08 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 79 | 15/01/02 | |
President | 53 | 01/08/03 | |
Keiko Yamasaki
BRD | Director/Board Member | 74 | 15/01/02 |
Hiroshi Akitomo
BRD | Director/Board Member | 63 | 01/06/02 |
Chief Tech/Sci/R&D Officer | 55 | 15/01/02 | |
Kunio Iwatani
BRD | Director/Board Member | 82 | 01/03/16 |
Ken Fujioka
ADM | Chief Administrative Officer | 56 | 01/11/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 42 945 100 | 38 981 198 ( 90,77 %) | 2 ( 0,000005 %) | 90,77 % |
Información de la empresa
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-13,25 % | 32,96 M | |
+14,40 % | 74,45 mil M | |
+11,35 % | 9180,02 M | |
+60,16 % | 5030,08 M | |
-12,85 % | 5021,85 M | |
+1,60 % | 3820,27 M | |
-19,20 % | 2409,95 M | |
+19,41 % | 2391,59 M | |
-27,46 % | 2274,04 M | |
+24,62 % | 2262,33 M |
- Bolsa de valores
- Acciones
- Acción 4586
- Empresa MedRx Co., Ltd